IQVIA Holdings Inc
IQV149.046USD
-1.234-0.82%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
26.25BMarktkapitalisierung
19.12KGV TTM
mehr Informationen über IQVIA Holdings Inc Unternehmen
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Unternehmensinformationen
Unternehmens-codeIQV
Name des UnternehmensIQVIA Holdings Inc
IPO-datumMay 09, 2013
Gegründet am2016
CEOMr. Ari Bousbib
Anzahl der mitarbeiter88000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 09
Addresse2400 Ellis Road
StadtDURHAM
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl27703
Telefon19199982000
Websitehttps://ir.iqvia.com/
Unternehmens-codeIQV
IPO-datumMay 09, 2013
Gegründet am2016
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
-0.84%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
15.24K
+4.31%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
947.00
-10.24%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
-0.84%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
15.24K
+4.31%
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Americas
7.36B
47.75%
Europe & Africa Region
4.92B
31.94%
Asia Pacific Region
3.13B
20.31%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Sat, Apr 26
Update-Zeit: Sat, Apr 26
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
11.37%
Harris Associates L.P.
6.43%
BlackRock Institutional Trust Company, N.A.
5.72%
GIC Private Limited
5.18%
State Street Global Advisors (US)
4.47%
Other
66.83%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
11.37%
Harris Associates L.P.
6.43%
BlackRock Institutional Trust Company, N.A.
5.72%
GIC Private Limited
5.18%
State Street Global Advisors (US)
4.47%
Other
66.83%
Art
Aktionäre
Anteil
Investment Advisor/Hedge Fund
42.88%
Investment Advisor
32.28%
Sovereign Wealth Fund
6.25%
Hedge Fund
5.20%
Pension Fund
4.26%
Research Firm
2.47%
Bank and Trust
2.40%
Individual Investor
0.87%
Insurance Company
0.06%
Other
3.33%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
2009
171.86M
97.47%
+3.41M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
2023Q1
1870
169.28M
91.24%
-7.20M
2022Q4
1852
168.30M
90.60%
-9.63M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
20.05M
11.37%
+108.12K
+0.54%
Dec 31, 2024
Harris Associates L.P.
11.34M
6.43%
+1.16M
+11.36%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.08M
5.72%
-49.64K
-0.49%
Dec 31, 2024
GIC Private Limited
9.13M
5.18%
+9.13M
--
Aug 13, 2024
State Street Global Advisors (US)
7.88M
4.47%
+116.07K
+1.49%
Dec 31, 2024
CPP Investment Board
4.28M
2.43%
+712.96K
+19.98%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.18M
2.37%
+77.98K
+1.90%
Dec 31, 2024
AllianceBernstein L.P.
3.59M
2.04%
-298.60K
-7.67%
Dec 31, 2024
Farallon Capital Management, L.L.C.
3.12M
1.77%
-47.93K
-1.51%
Dec 31, 2024
Lazard Asset Management, L.L.C.
2.62M
1.49%
-712.19K
-21.36%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
First Trust Nasdaq Lux Digi Health Solutions ETF
5.74%
Langar Global HealthTech ETF
5.01%
VanEck Biotech ETF
4.19%
Global X Telemedicine & Digital Health ETF
2.91%
iShares Biotechnology ETF
2.86%
American Century Mid Cap Growth Impact ETF
2.34%
Invesco Bloomberg Pricing Power ETF
1.92%
Fidelity Digital Health ETF
1.87%
Running Oak Efficient Growth ETF
1.67%
American Century Focused Large Cap Value ETF
1.57%
Mehr Anzeigen
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil5.74%
Langar Global HealthTech ETF
Anteil5.01%
VanEck Biotech ETF
Anteil4.19%
Global X Telemedicine & Digital Health ETF
Anteil2.91%
iShares Biotechnology ETF
Anteil2.86%
American Century Mid Cap Growth Impact ETF
Anteil2.34%
Invesco Bloomberg Pricing Power ETF
Anteil1.92%
Fidelity Digital Health ETF
Anteil1.87%
Running Oak Efficient Growth ETF
Anteil1.67%
American Century Focused Large Cap Value ETF
Anteil1.57%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten